Pharmacovigilance for AI
AI agents now sell, trade, delete and attack on their own, yet almost no organisation watches them the way we already watch medicines. It is time for pharmacovigilance for AI: a live register, drift monitoring, a named owner and a fast way to pull an agent when it misbehaves, grounded in three fresh incidents, a Johns Hopkins counter-model and Singapore's decision to fold agents into binding banking rules.















